Phosphatidylinositol 3-kinase regulates macrophage responses to double-stranded RNA and encephalomyocarditis virus

Journal of Innate Immunity

Volumn 2, Issue 1, 2009, Pages 77-86

  Freudenburg, Wieke ^a   Moran, Jason M ^a   Lents, Nathan H ^b   Baldassare, Joseph J ^a   Buller, R Mark L ^a   Corbett, John A ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Inflammation; Innate immunity; Macrophages; Nitric oxide; Virus infection

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; DOUBLE STRANDED RNA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARDIOVIRUS INFECTIONS; CASPASE 3; CELL LINE; CYCLOOXYGENASE 2; ENCEPHALOMYOCARDITIS VIRUS; INTERLEUKIN-1BETA; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, DOUBLE-STRANDED;

EID: 77953430564     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000243785     Document Type: Article

References (42)

1. Heitmeier MR, Scarim AL, Corbett JA: Double- stranded RNA-induced inducible nitricoxide synthase expression and interleukin-1 release by murine macrophages requires NF-κB activation. J Biol Chem 1998; 273: 15301-15307.
2. Steer SA, Moran JM, Maggi LB, Jr., Buller RM, Perlman H, Corbett JA: Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J Immunol 2003; 170: 1070-1076.
3. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by Interferon-γ-induced nitric oxide synthase. Science 1993; 261: 1445-1448.
4. Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadl C, Lowenstein JM, Lowenstein CJ: An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999; 10: 21-28.
5. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A: Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996; 97: 1837-1843.
6. Flodstrom M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E, Sarvetnick N: A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 2001; 281: 205-215.
7. Steer SA, Corbett JA: The role and regulation of COX-2 during viral infection. Viral Immunol 2003; 16: 447-460.
8. Iordanov MS, Paranjape JM, Zhou A, Wong J, Williams BR, Meurs EF, Silverman RH, Magun BE: Activation of p38 mitogen-activated protein kinase and c-Jun NH 2 -terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNAse l, protein kinase R, and alternative pathways. Mol Cell Biol 2000; 20: 617-627.
9. Maggi LB, Jr., Moran JM, Buller RM, Corbett JA: Erk activation is required for doublestranded RNA- and virus-induced interleukin- 1 expression by macrophages. J Biol Chem 2003; 278: 16683-16689.
10. Liou HC, Baltimore D: Regulation of the NFκB/Rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol 1993; 5: 477-487.
11. Maggi LB, Jr., Moran JM, Scarim AL, Ford DA, Yoon JW, McHowat J, Buller RM, Corbett JA: Novel role for calcium-independent phospholipase a 2 in the macrophage antiviral response of inducible nitric-oxide synthase expression. J Biol Chem 2002; 277: 38449-38455.
12. Steer SA, Moran JM, Christmann BS, Maggi LB, Jr., Corbett JA: Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase- expression by macrophages. J Immunol 2006; 177: 3413-3420
13. Maggi LB, Jr., Heitmeier MR, Scheuner D, Kaufman RJ, Buller RM, Corbett JA: Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J 2000; 19: 3630-3638.
14. Moran JM, Moxley MA, Buller RM, Corbett JA: Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages. J Virol 2005; 79: 10226-10236.
15. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70: 535-602.
16. Mannova P, Beretta L: Activation of the NRas- PI3K-Akt-mTOR pathway by hepatitis c virus: Control of cell survival and viral replication. J Virol 2005; 79: 8742-8749.
17. Johnson RA, Wang X, Ma XL, Huong SM, Huang ES: Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol 2001; 75: 6022-6032.
18. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW: Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2002; 277: 492-501.
19. Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC: The torrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-AktmTOR signalling pathway. Nat Rev Microbiol 2008; 6: 266-275.
20. Cooray S: The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol 2004; 85: 1065-1076.
21. Weinstein SL, Finn AJ, Dave SH, Meng F, Lowell CA, Sanghera JS, DeFranco AL: Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via Interferon-β . J Leukoc Biol 2000; 67: 405-414.
22. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, et al.: 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for Ras activation in CHO cells. Proc Natl Acad Sci USA 1994; 91: 7415-7419.
23. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER: Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol 1993; 150: 888-895.
24. Bae YS, Eun HM, Yoon JW: Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 1989; 170: 282-287.
25. Phillips-Mason PJ, Raben DM, Baldassare JJ: Phosphatidylinositol 3-kinase activity regulates -thrombin-stimulated G1 progression by its effect on cyclin D1 expression and cyclin- dependent kinase 4 activity. J Biol Chem 2000; 275: 18046-18053.
26. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
27. Hill JR, Corbett JA, Kwon G, Marshall CA, McDaniel ML: Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 1996; 271: 22672-22678.
28. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA: Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 1998; 160: 2684-2691.
29. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM: Phosphorylation and regulation of Akt/ PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101.
30. Hibbs JBJ, Vavrin TR, Granger Z, Drapier DL, Amber JC, Lancaster JR Jr: Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L -arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron; in Moncada HE (ed): Nitric Oxide from L -Arginine: A Bioregulatory System. New York, Elsevier Science, 1990, pp 189-223.
31. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM, Holtzman MJ: CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 2005; 11: 1180-1187.
32. Song G, Ouyang G, Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9: 59-71.
33. Boatright KM, Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol 2003; 15: 725-731.
34. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, Dimmeler S: Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999; 274: 6823-6826.
35. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778-809, table of contents.
36. Prejean C, Sarma T, Kurnasov O, Usacheva A, Hemmings B, Cantley L, Fruman DA, Morrison LA, Buller RM, Colamonici OR: Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J Immunol 2001; 167: 4553-4559.
37. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990; 62: 379-390.
38. Clemens MJ, Elia A: The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 1997; 17: 503-524.
39. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M: Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006; 103: 8459-8464.
40. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737.
41. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001; 413: 732-738.
42. Sotsios Y, Ward SG: Phosphoinositide 3-kinase: A key biochemical signal for cell migration in response to chemokines. Immunol Rev 2000; 177: 217-235.